| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 46.698.497 $ | +2.100.518 $ | +13,3 % | 7 | 47.386.662 $ | -3.872.922 $ | -2,8 % | 9 | 51.259.584 $ | -107.893.691 $ | +58,0 % | 9 | ||||
| iSHARES TRUST | → 0 | 17.312.064 $ | -2.664.816 $ | -13,3 % | 1 | 19.976.880 $ | +735.504 $ | +3,8 % | 1 | 19.241.376 $ | -115.790.642 $ | -85,8 % | 1 | ||
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Neutral | 12.535.825 $ | +4.442.451 $ | +54,9 % | 1 | 8.093.374 $ | -3.779.546 $ | -31,8 % | 1 | 11.872.920 $ | +1.830.408 $ | +18,2 % | 1 |
| Foghorn Therapeutics Inc. | FHTX | → 0 | Neutral | 7.522.578 $ | -975.731 $ | -11,5 % | 1 | 8.498.309 $ | +802.618 $ | +10,4 % | 1 | 7.695.691 $ | +299.014 $ | +4,0 % | 1 |
| Alector, Inc. | ALEC | → 0 | Neutral | 2.811.895 $ | +771.637 $ | +37,8 % | 1 | 2.040.258 $ | -1.831.002 $ | -47,3 % | 1 | 3.871.260 $ | +2.040.259 $ | +111,4 % | 1 |
| PMV Pharmaceuticals, Inc. | PMVP | → 0 | Neutral | 3.258.277 $ | -26.277 $ | -0,8 % | 1 | 3.284.554 $ | -394.146 $ | -10,7 % | 1 | 3.678.700 $ | +893.398 $ | +32,1 % | 1 |
| RAPT Therapeutics, Inc. | RAPT | → 0 | 2.785.266 $ | +664.451 $ | +31,3 % | 1 | 2.120.815 $ | +1.462.943 $ | +222,4 % | 1 | |||||
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 2.554.584 $ | +572.654 $ | +28,9 % | 1 | 1.981.930 $ | +851.967 $ | +75,4 % | 1 | 1.129.963 $ | +345.961 $ | +44,1 % | 1 |
| Tenaya Therapeutics, Inc. | TNYA | → 0 | Neutral | 703.274 $ | -19.400 $ | -2,7 % | 1 | 722.674 $ | -922.768 $ | -56,1 % | 1 | 1.645.442 $ | +1.024.643 $ | +165,1 % | 1 |
| SURROZEN INC | → 0 | 3.417 $ | +0 $ | +0,0 % | 1 | 3.417 $ | +325 $ | +10,5 % | 1 | ||||||
| 46.698.497 $ | +2.100.518 $ | +13,3 % | 7 | 47.386.662 $ | -3.872.922 $ | -2,8 % | 9 | 51.259.584 $ | -107.893.691 $ | +58,0 % | 9 | ||||